Subscribe
Sign In
Tag: CBT > Cannabis Schedule: Page 8
Legislation and Regulation
MORE Act Clears Rules Committee, Heads to House Floor
The committee advanced four amendments for the legislation to end the federal prohibition of cannabis; House floor consideration expected April 1.
March 31, 2022
D.C.
MORE Act Receives 10 More Proposed Amendments, 15 Total
As the federal cannabis reform bill is teed up in the House, Maryland Rep. Andy Harris and others have offered possible changes to consider.
March 29, 2022
Adult-Use Legalization Bill
MORE Act Committee Hearing Postponed to March 30
The broad federal cannabis reform bill has already received five proposed amendments for the House Rules Committee to consider.
March 28, 2022
D.C.
MORE Act Vote on Deck in U.S. House, Again
After first passing the legislation to remove cannabis as a federally controlled substance in 2020, House members could vote on the bill next week.
March 25, 2022
Legislation and Regulation
Reps. Mace and Lee Introduce Resolution Instructing UN to Deschedule Cannabis
The U.S. representatives came together in bipartisan backing of a resolution they say would support global research and reform
March 18, 2022
Michigan
Michigan Legislation Aims to Remove Cannabis as Schedule I Drug
While the state has an adult-use cannabis program, the bill’s sponsor says the plant’s designation as a controlled substance still has broad implications.
March 9, 2022
Adult-Use Legalization Bill
GOP Congresswoman Mace Spices Up Federal Cannabis Legalization
The South Carolina Republican introduced the States Reform Act, an alternative path to broad cannabis reform.
November 15, 2021
International
Following Mexico’s Issuance of Medical Cannabis Regulations, Clever Leaves Enters Market
CEO Kyle Detwiler shared the company’s plans with Hemp Grower and Cannabis Business Times.
July 6, 2021
Legislation and Regulation
Industry Weighs in on DEA Cannabis Research Final Rule
Stakeholders express concern that the agency will weigh applicants’ compliance with federal law when granting registrations.
December 23, 2020
Adult-Use Legalization Bill
Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research
The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.
January 17, 2020
Legislation and Regulation
Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market
Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.
December 6, 2019
Legislation and Regulation
Key House Committee Approves MORE Act to Federally Decriminalize Cannabis
The House Judiciary Committee approved the legislation in a bipartisan vote of 24 to 10, sending it for a floor vote.
November 20, 2019
Previous Page
Page 8 of 9
Next Page